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First-line diagnostic investigations for endometriosis are physical examination and
pelvic ultrasound. The second-line investigations are: targeted pelvic examination
performed by an expert clinician, transvaginal ultrasound performed by an expert
physician sonographer (radiologist or gynaecologist), and pelvic MRI. Management of
endometriosis is recommended when the disease has a functional impact.
Recommended first-line hormonal therapies for the management of endometriosis-
related pain are combined hormonal contraceptives (CHCs) or the 52mg
levonorgestrel-releasing intrauterine system (IUS). There is no evidence base on which
to recommend systematic preoperative hormonal therapy solely to prevent surgical
complications or facilitate surgery. After surgery for endometriosis, a CHC or 52mg
levonorgestrel-releasing IUS is recommended as first-line treatment when pregnancy is
not desired. In the event of failure of the initial treatment, recurrence, or multiorgan
involvement, a multidisciplinary team meeting is recommended, involving physicians,
surgeons and other professionals. A laparoscopic approach is recommended for
surgical treatment of endometriosis. HRT can be offered to postmenopausal women
who have undergone surgical treatment for endometriosis. Antigonadotrophic
hormonal therapy is not recommended for patients with endometriosis and infertility to
increase the chances of spontaneous pregnancy, including postoperatively. Fertility
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